FRACTYL HEALTH, INC.
جودة البيانات: 83%
GUTS
NASDAQ
Manufacturing
Measuring & Analyzing Instruments
KWD 0.51
KWD 0.00
(0.00%)
6 months return
—
Momentum
Neutral
Free cash flow
-90.89 M
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
N/A
ROIC-112.67%
Net MarginN/A
Op. MarginN/A
الأمان
Debt / Equity
N/A
Current Ratio4.27
Interest CoverageN/A
التقييم
PE (TTM|NTM)
-0.51 | -0.81
أعلى من متوسط القطاع (-1.50)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Negative free cash flow of -90.89 M
Price History
الاتجاهات المالية
السعر المستهدف للمحللين
5 محللين
Buy
+930.1%
upside to target
الحالي
KWD 0.51
Consensus Target
KWD 5.24
KWD 2.00
أدنى
KWD 8.00
أعلى
التوقعات
مكرر الربحية المستقبلي
-0.81
ربحية السهم المستقبلية
-KWD 0.57
الإيرادات المقدّرة
29.77 M
مفاجآت الأرباح
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: -KWD 0.16
·
Rev Est: 0.0
| Q12025 | Q22025 | Q32025 | Q42025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|
| Reported | -KWD 0.49 | -KWD 0.57 | -KWD 0.71 | -KWD 0.07 | — | — |
| Estimate | -KWD 0.50 | -KWD 0.36 | -KWD 0.32 | -KWD 0.18 | -KWD 0.16 | -KWD 0.16 |
| المفاجأة | +2.00% | -58.33% | -124.68% | +61.11% | — | — |
Growth
Rev 5Y: N/A · Earnings 1Y: N/A
Growth
Rev 5Y: N/A · Earnings 1Y: N/A| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
Profitability
ROE: N/A · Net Margin: N/A
Profitability
ROE: N/A · Net Margin: N/A| Revenue (TTM) | N/A | Net Income (TTM) | -140.95 M |
| ROE | N/A | ROA | -159.92% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -90.89 M |
| ROIC | -112.67% | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: 4.27
Safety
D/E: N/A · Current: 4.27| Debt / Equity | N/A | Current Ratio | 4.27 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 61.02 M | Tangible Book Value | -3.18 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -0.51 · EV/EBITDA: N/A
Valuation
P/E: -0.51 · EV/EBITDA: N/A| P/E Ratio | -0.51 | Forward P/E | -0.81 |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 2.44 | Fwd Earnings Yield | N/A |
| FCF Yield | -125.35% | ||
| Market Cap | 72.50 M | Enterprise Value | -5.15 M |
Per Share
EPS: -1.86 · FCF/Share: -0.57
Per Share
EPS: -1.86 · FCF/Share: -0.57| EPS (Diluted TTM) | -1.86 | Revenue / Share | N/A |
| FCF / Share | -0.57 | OCF / Share | -0.57 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 64.48% · CapEx/Rev: N/A
Efficiency
FCF Conv: 64.48% · CapEx/Rev: N/A| CapEx / Revenue | N/A | FCF Conversion | 64.48% |
| SBC-Adj. FCF | -100.93 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | — | — |
| Net Income | -140.95 M | -68.69 M |
| EPS (Diluted) | -1.86 | -1.62 |
| Gross Profit | 43,000.0 | 43,000.0 |
| Operating Income | -96.82 M | -93.53 M |
| EBITDA | — | — |
| R&D Expenses | 74.54 M | 70.47 M |
| SG&A Expenses | 22.28 M | 23.10 M |
| D&A | — | — |
| Interest Expense | — | — |
| Income Tax | 0.0 | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Total Assets | 121.40 M | 108.08 M |
| Total Liabilities | 111.94 M | 79.65 M |
| Shareholders' Equity | 9.46 M | 28.42 M |
| Total Debt | — | — |
| Cash & Equivalents | 81.54 M | 67.46 M |
| Current Assets | 87.58 M | 71.76 M |
| Current Liabilities | 18.33 M | 19.78 M |
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1605 نظير)
مقارنة بشركات مشابهة في Manufacturing
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1605 نظير) مقارنة بشركات مشابهة في Manufacturing| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -0.5 | -1.5 |
| P/B | — | 1.6 |
| ROE % | — | -54.7 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.7 |
| D/E | — | 0.3 |
ETFs Holding This Stock
ETFs Holding This Stock
BRSIX
BRSIX
0.08% weight
{"event":"ticker_viewed","properties":{"ticker":"GUTS","listing_kind":"stock","pathname":"/stocks/guts","exchange":"NASDAQ","country":"US"}}